Cover Illustration
2020, Vol.4 No.3 The cover picture shows EGFR signal transduction: when the extracellular domain binds to growth factors or other ligands, EGFR dimerization with other members of the family results in phosphorylation of tyrosine kinase and activating various signaling pathways downstream of EGFR, such as MAPK, PI3K/Akt and STAT, leading to gene transcription, cell cycle progression and apoptosis. In addition, the advances of small-molecule inhibitors on the target of EGFR include 4-anilinoquinazolines, “U-type” pyrimidines, thiophene [3,2-d] pyrimidines, oxyisoindoles and amino benzimidazoles. More details are discussed in the article by Zi et al. on page 200011.